Page 9 - JaKita 08st Edition 2021

TOP REPORT 9

central government’s program with hopes to reduce of COVID-19 vaccine is the inactivated SARS-CoV2
the transmission and mortality rate, as well as strive Virus (antigen), Al (OH3) or aluminium hydroxide as
for the herd immunity,” said Jakarta governor Anies an adjuvant to strengthen the immune response,
Baswedan at City Hall. sodium chloride (salt) to set the vaccine solution
isotonic, and disodium hydrogen phosphate to
From number of events occurred in several countries, support the power of hydrogen (pH). After our body
COVID-19 vaccination is proven able to reduce and getting a vaccine injection, he explained, vaccine will
minimize the symptoms and risk of death due to stimulate the body’s immunity against SARS-CoV-2.
COVID-19. Citing the page of the Indonesian Ministry
of Health, based on reports from case studies in the One of vaccines that have been distributed is Sinovac,
UK and America, COVID-19 vaccine is able to reduce which was declared to have efficacy up to 65.3%
the risk of death by 75-85%. during clinical trials, means there is a decrease
in cases up to 65.3% in the group who gets
Pursuing Vaccination the vaccine and who doesn’t.
#ayov aksindulu
#letsgetvaccinated
To reduce transmissions and To achieve the efficacy rate,
deaths due to COVID-19, vaccine must be administered
Jakarta government is twice, one dose each and
striving to overcome given within a gap of 2-4
the problem, which has weeks. The dosing and
been spreading rapidly intervals are based on the
throughout the city. One results of a study which
of the ways is to conduct states that antibody
COVID-19 vaccination titer can reach optimal
programs every day by levels after two doses of
involving many parties. injections.

Based on data from Iwan Setiawan ensured that
Indonesian Health Ministry, before carrying out distribution,
vaccination target in Jakarta is COVID-19 vaccine had been
th
8,395,427 people. Until August 6 clinically tested by a special team
2021, total participants for the first dose from across agencies. During the
of vaccination has reached 97.84 percent monitoring phase of the clinical trial, the team
or 8,213,765, which exceeded the target of 7.5 million found side effects of vaccine: mild side effects include
given by President Joko Widodo. pain at the injection site, muscle pain (myalgia) and
fever. Basically, the fever is mild and will disappear
The vaccines used in the vaccination program in after 1-3 days.
Jakarta are CoronaVac and AstraZeneca. The two
th
vaccines were brought in by PT Bio Farma, a state- As of July 24 2021, total finished and bulk vaccines
owned enterprise (BUMN) which is also tasked with altogether have reached 86.9 million doses.
conducting clinical trials of COVID-19 vaccines According to Iwan Setiawan, as many as 65.8
imported by the government. million doses of it have been distributed to people
throughout Indonesia. The rest are still waiting for the
Head of Corporate Communication PT Bio Farma release certificate from the Indonesia Food and Drug
(Persero), Iwan Setiawan explained that the content Monitoring Agency (BPOM).

8th EDITION 2021
Sarana Informasi Pemerintah Provinsi DKI Jakarta